Publications by authors named "Kristin Freudenberg"

Under physiological conditions, CD4 regulatory T (Treg) cells expressing the transcription factor Foxp3 are generated in the thymus [thymus-derived Foxp3 Treg (tTregs) cells] and extrathymically at peripheral sites [peripherally induced Foxp3 Treg (pTreg) cell], and both developmental subsets play non-redundant roles in maintaining self-tolerance throughout life. In addition, a variety of experimental and modalities can extrathymically elicit a Foxp3 Treg cell phenotype in peripheral CD4Foxp3 T cells, which has attracted much interest as an approach toward cell-based therapy in clinical settings of undesired immune responses. A particularly notable example is the induction of Foxp3 expression and Treg cell activity (iTreg cells) in initially naive CD4Foxp3 T cells through T cell receptor (TCR) and IL-2R ligation, in the presence of exogenous TGF-β.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Kristin Freudenberg"

  • - Kristin Freudenberg's research primarily focuses on the induction and role of regulatory T (Treg) cells in immune responses, emphasizing the significance of Foxp3 expression in both thymus-derived and peripheral Treg cells.
  • - A key finding from her 2019 article highlights the crucial contribution of TGF-β and IL-2 receptor signaling pathways in promoting Foxp3 expression in naïve CD4 T cells, which has implications for therapeutic strategies in controlling undesirable immune responses.
  • - Freudenberg's work suggests potential clinical applications for manipulating Treg cell development, paving the way for innovative cell-based therapies aimed at enhancing immune tolerance in various autoimmune conditions.